Bank of Montreal’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-8,429
| Closed | -$442K | – | 5256 |
|
|
2020
Q3 | $442K | Sell |
8,429
-5,697
| -40% | -$236K | ﹤0.01% | 2380 |
|
|
2020
Q2 | $476K | Buy |
14,126
+4,696
| +50% | +$150K | ﹤0.01% | 2284 |
|
|
2020
Q1 | $228K | Sell |
9,430
-6,272
| -40% | -$175K | ﹤0.01% | 2283 |
|
|
2019
Q4 | $310K | Buy |
15,702
+3,581
| +30% | +$57.3K | ﹤0.01% | 2923 |
|
|
2019
Q3 | $157K | Buy |
12,121
+350
| +3% | +$4.23K | ﹤0.01% | 3058 |
|
|
2019
Q2 | $146K | Buy |
11,771
+8,816
| +298% | +$117K | ﹤0.01% | 3106 |
|
|
2019
Q1 | $43K | Sell |
2,955
-153
| -5% | -$1.95K | ﹤0.01% | 3400 |
|
|
2018
Q4 | $35K | Sell |
3,108
-53,366
| -94% | -$743K | ﹤0.01% | 3432 |
|
|
2018
Q3 | $1.49M | Buy |
56,474
+10,698
| +23% | +$289K | ﹤0.01% | 1819 |
|
|
2018
Q2 | $936K | Buy |
45,776
+43,894
| +2,332% | +$942K | ﹤0.01% | 2038 |
|
|
2018
Q1 | $34K | Buy |
1,882
+152
| +9% | +$2.53K | ﹤0.01% | 3389 |
|
|
2017
Q4 | $24K | Sell |
1,730
-254
| -13% | -$3.43K | ﹤0.01% | 3537 |
|
|
2017
Q3 | $37K | Buy |
1,984
+302
| +18% | +$5.05K | ﹤0.01% | 3344 |
|
|
2017
Q2 | $29K | Hold |
1,682
| – | – | ﹤0.01% | 3403 |
|
|
2017
Q1 | $22K | Buy |
1,682
+254
| +18% | +$3.98K | ﹤0.01% | 3346 |
|
|
2016
Q4 | $20K | Buy |
1,428
+106
| +8% | +$1.4K | ﹤0.01% | 3400 |
|
|
2016
Q3 | $16K | Sell |
1,322
-433
| -25% | -$5.09K | ﹤0.01% | 3438 |
|
|
2016
Q2 | $19K | Sell |
1,755
-623
| -26% | -$6.43K | ﹤0.01% | 3414 |
|
|
2016
Q1 | $23K | Buy |
2,378
+77
| +3% | +$829 | ﹤0.01% | 3358 |
|
|
2015
Q4 | $34K | Buy |
2,301
+664
| +41% | +$11.1K | ﹤0.01% | 3192 |
|
|
2015
Q3 | $27K | Buy |
1,637
+1,204
| +278% | +$24.6K | ﹤0.01% | 3141 |
|
|
2015
Q2 | $10K | Buy |
+433
| New | +$8.62K | ﹤0.01% | 3503 |
|
|
2014
Q4 | – | Sell |
-879
| Closed | -$10K | – | 4240 |
|
|
2014
Q3 | $10K | Sell |
879
-1,240
| -59% | -$14.1K | ﹤0.01% | 3664 |
|
|
2014
Q2 | $26K | Sell |
2,119
-104,140
| -98% | -$1.23M | ﹤0.01% | 3481 |
|
|
2014
Q1 | $1.24M | Buy |
106,259
+105,380
| +11,989% | +$1.78M | ﹤0.01% | 1564 |
|
|
2013
Q4 | $16K | Hold |
879
| – | – | ﹤0.01% | 3295 |
|
|
2013
Q3 | $13K | Hold |
879
| – | – | ﹤0.01% | 3359 |
|
|
2013
Q2 | $13K | Buy |
+879
| New | +$11.6K | ﹤0.01% | 3222 |
|
Bank of Montreal's MNTA Position: Q4 2020 in Review
Bank of Montreal sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 8,429 shares — an estimated $442K sold.
Bank of Montreal first reported a position in MNTA in Q2 2013 and held it in 28 quarters. The position peaked at $1.49M in Q3 2018. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Bank of Montreal reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Bank of Montreal sold 8,429 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $442K.
- Bank of Montreal first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 28 quarters.
- Bank of Montreal's Momenta Pharmaceuticals, Inc. position peaked at $1.49M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Bank of Montreal's 13F filing for Q4 2020, filed 12 Feb 2021.